Q1 2023 Holdings
Filed 2023-05-15 | 36 holdings | $270.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $51.1M | 321,055 | 18.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $35.0M | 329,200 | 12.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $22.2M | 80,000 | 8.2% |
| Karuna Therapeutics Inc | COM | 48576A100 | $16.1M | 88,831 | 6.0% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $14.5M | 90,821 | 5.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $13.6M | 36,404 | 5.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $13.0M | 84,719 | 4.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $11.5M | 118,465 | 4.3% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $10.4M | 51,175 | 3.8% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $9.8M | 404,615 | 3.6% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $9.2M | 26,928 | 3.4% |
| Sarepta Therapeutics IncCall | CALL | 803607900 | $8.3M | 60,000 | 3.1% |
| Novo-Nordisk A SCall | CALL | 670100905 | $8.0M | 50,000 | 2.9% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $7.1M | 102,307 | 2.6% |
| Karuna Therapeutics IncPut | PUT | 48576A950 | $5.4M | 30,000 | 2.0% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $4.6M | 37,108 | 1.7% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $4.6M | 45,000 | 1.7% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $3.6M | 40,000 | 1.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $3.2M | 15,971 | 1.2% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $2.9M | 5,088 | 1.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $2.3M | 41,600 | 0.8% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $2.2M | 7,114 | 0.8% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $1.8M | 90,451 | 0.7% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $1.5M | 169,277 | 0.5% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $1.4M | 6,905 | 0.5% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $1.2M | 157,763 | 0.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.1M | 68,408 | 0.4% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $966.5K | 51,795 | 0.4% |
| Waters Corp(WAT) | COM | 941848103 | $880.9K | 2,845 | 0.3% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $853.0K | 22,759 | 0.3% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $727.2K | 45,253 | 0.3% |
| Altimmune IncCall | CALL | 02155H900 | $422.0K | 100,000 | 0.2% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $385.2K | 256,800 | 0.1% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $244.7K | 8,339 | 0.1% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $241.1K | 5,000 | 0.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $172.4K | 38,057 | 0.1% |